[1] Kim YH, Park JW, Kim JS, et al.Twenty-Five- to Twenty-Seven-Year Results of a Cemented vs a Cementless Stem in the Same Patients Younger Than 50 Years of Age. J Arthroplasty. 2016 ;31(3):662-667.[2] Gallo J,Goodman SB,Konttinen YT, et al. Osteolysis around total knee arthroplasty: A review of pathogenetic mechanisms. Acta Biomaterialia.2013;9(9):8046-8058.[3] Bitar D, Parvizi J. Biological response to prosthetic debris. World J Orthop. 2015;6(2):172-189.[4] Kurtz S, Ong K, Lau E, et al.Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780-785.[5] Wang Z,Liu N,Kang L,et al.Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis.Autophagy.2015; 11(12):2358-2369.[6] Tsuji-Takechi K, Negishi-Koga T, Sumiya E, et al. Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development. Proc Natl Acad Sci U S A. 2012;109(7):2561-2566[7] Howie DW, Neale SD, Haynes DR, et al. Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.Inflammopharmacology. 2013; 21(6): 389-396.[8] Lee SC, Li A, Calo S, et al. Calcineurin Plays Key Roles in the Dimorphic Transition and Virulence of the Human Pathogenic Zygomycete Mucor circinelloides.Plos Pathogens.2013;9(9): 289-290.[9] Steinbach WJ, Reedy JL, Jr CR, et al.Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.Nature Reviews Microbiology. 2007;5(6): 418-430.[10] Juvvadi PR, Lamoth F, Steinbach WJ. Calcineurin as a multifunctional regulator: Unraveling novel functions in fungal stress responses, hyphal growth, drug resistance, and pathogenesis. Fungal Biology Reviews.2014;28(2–3):56-69.[11] Chen YL, Kozubowski L, Cardenas ME, et al. On the Roles of Calcineurin in Fungal Growth and Pathogenesis. Current Fungal Infection Reports.2010;4(4):244-255.[12] Hudson MB, Price SR. Calcineurin: A poorly understood regulator of muscle mass. Int J Biochem Cell Biol. 2013; 45(10): 2173-2178.[13] Takayanagi H.The Role of NFAT in Osteoclast Formation. Annals of the New York Academy of Sciences. 2007;1116: 227-237.[14] Aliprantis AO, Glimcher LH.NFATc1 in Inflammatory and Musculoskeletal Conditions. Advances in Experimental Medicine & Biology.2010;658(658):69-75.[15] Hogan PG,Chen L,Nardone J,et al.Transcriptional regulation by calcium, calcineurin, and NFAT. Genes & Development. 2003;17(18):2205-2232.[16] Sanjuan J, Olivares J.Identification of a putative regulator of early T cell activation genes.Science.1988;241(4862): 202-205.[17] Takayanagi H,Kim S,Koga T,et al. Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts. Developmental Cell.2002;3(6):889-901.[18] Liu FX, Wu CL, Zhu ZA, et al.Calcineurin/NFAT pathway mediates wear particleinduced TNF-α release and osteoclastogenesis from mice bone marrow macrophages in vitro. Acta Pharmacologica Sinica.2013;34(11): 1457-1466.[19] Fukunaga T. Evidence for osteocyte regulation of bone homeostasis through RANKL expression.Nature Medicine.2011;17(10):1231-1234.[20] Erlebacher A, Filvaroff EH, Gitelman SE, et al.Toward a molecular understanding of skeletal development. Cell. 1995;80(3):371-378.[21] Zaidi M.Skeletal remodeling in health and disease.Nature Medicine.2007; 13(7):791-801.[22] O'Brien CA.Control of RANKL gene expression. Bone.2010; 46(4):911-919.[23] Teitelbaum SL, Ross FP.Genetic regulation of osteoclast development and function. Nature Reviews Genetics.2003; 4(8):638-649.[24] Rahman MM,Takeshita S,Matsuoka K,et al. Proliferation-coupled osteoclast differentiation by RANKL: Cell density as a determinant of osteoclast formation. Bone. 2015; 81:392-399.[25] Feng X, Teitelbaum SL.Osteoclasts: New Insights. Bone Res. 2013;1(1):11-26.[26] Yu W, Chen J, Xiong Y, et al. Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. J Biol Chem. 2012;287(17):13694-13704.[27] He Y,Staser K,Rhodes SD,et al.Erk1 positively regulates osteoclast differentiation and bone resorptive activity. Plos One.2011;6(9):e24780-e24780.[28] Ikeda K,Takeshita S.The role of osteoclast differentiation and function in skeletal homeostasis. J Biochem. 2016;159(1):1-8. [29] Aliprantis AO, Ueki Y,Sulyanto R, et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008;118(11):3775-3789.[30] Miyamoto T. Regulators of osteoclast differentiation and cell-cell fusion. Keio J Med. 2011;60(4):101-105. [31] Kim JH,Youn BU, Kim K, et al. Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts. Cell Death Differ. 2014;21(10):1613-1621.[32] Zhao B, Takami M, Yamada A, et al.Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.Nature Medicine.2009;15(9):1066-1071.[33] Asagiri M, Sato K, Usami T, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 2005;202(9):1261-1269.[34] Koga T, Matsui Y, Asagiri M, et al. NFAT and Osterix cooperatively regulate bone formation. Nature Medicine.2005; 11(11):880-885.[35] Feng X. RANKing Intracellular Signaling in Osteoclasts. IUBMB Life. 2005;57(6):389-395.[36] Choi SW, Park KI, Yeon JT, et al. Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. BMC Complement Altern Med.2014;14:35. [37] Zhang Y, He Y, Zong Y, et al. 17β-estradiol attenuates homocysteine-induced oxidative stress and inflammatory response as well as MAPKs cascade via activating PI3-K/Akt signal transduction pathway in Raw 264,7 cells. Acta Biochim Biophys Sin (Shanghai). 2015;47(2):65-72.[38] Gy?ri D, Csete D, Benk? S, et al. The Phosphoinositide 3-Kinase Isoform PI3Kβ Regulates Osteoclast-Mediated Bone Resorption in Humans and Mice.Arthritis Rheumatol. 2014;66(8):2210-2221.[39] Kim JA,Im S,Cantley LC,et al.Suppression of Nkx3.2 by phosphatidylinositol-3-kinase signaling regulates cartilage development by modulating chondrocyte hypertrophy.Cellular Signalling.2015:27(12):2389-2400.[40] Nüssleinvolhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila.Nature.1980; 287(5785):795-801.[41] Regard JB,Malhotra D,Gvozdenovic-Jeremic J,et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.Nature Medicine.2013; 19(11): 1505-1512.[42] Briggs LE, Burns TA, Lockhart MM, et al. Wnt/β-catenin and sonic hedgehog pathways interact in the regulation of the development of the dorsal mesenchymal protrusion. Dev Dyn. 2016;245(2):103-113.[43] Swarnkar G, Zhang K, Mbalaviele G, et al.Constitutive Activation of IKK2/NF-κB Impairs Osteogenesis and Skeletal Development. Plos One.2014;9(3):e91421.[44] Zhang R,Murakami S,Coustry F,et al.Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. Proc Natl Acad Sci U S A. 2006;103(2):365-370.[45] Kazmers NH, Mckenzie JA, Shen TS, et al. Hedgehog signaling mediates woven bone formation and vascularization during stress fracture healing.Bone.2015; 81:524-532.[46] Landgraeber S, Jäger M, Jacobs JJ, et al. The Pathology of Orthopedic Implant Failure Is Mediated by Innate Immune System Cytokines.Mediators Inflamm. 2014;2014:185150.[47] Rao A J, Gibon E, Ma T, et al. Revision joint replacement, wear particles, and macrophage polarization. Acta Biomaterialia. 2012;8(7):2815-2823.[48] Gallo J, Kamínek P, Zapletalová J, et al. [Is osteolysis associated with a stable total hip replacement asymptomatic?]. Acta Chir Orthop Traumatol Cech. 2004; 71(1):20-25.[49] Maloney W, Rosenberg A. What is the outcome of treatment for osteolysis?. J Am Acad Orthop Surg. 2008;16 Suppl 1: S26-32.[50] Deirmengian GK, Zmistowski B, O'Neil JT, et al. Management of acetabular bone loss in revision total hip arthroplasty. J Bone Joint Surg Am. 2011;93(19):1842-1852.[51] Garcia-Cimbrelo E, Garcia-Rey E, Cruz-Pardos A.The extent of the bone defect affects the outcome of femoral reconstruction in revision surgery with impacted bone grafting: a five- to 17-year follow-up study. J Bone Joint Surg Br. 2011; 93(11):1457-1464.[52] Konttinen YT,Zhao D,Beklen A,et al.The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res. 2005;(430):28-38. Review.[53] Ren PG, Irani A, Huang Z, et al.Continuous Infusion of UHMWPE Particles Induces Increased Bone Macrophages and Osteolysis. Clin Orthop Relat Res. 2011;469(1):113-122. [54] Yamashita T,Takahashi N,Udagawa N.New roles of osteoblasts involved in osteoclast differentiation. World J Orthop. 2012;3(11):175-181.[55] Zarubin T, Han J.Activation and signaling of the p38 MAP kinase pathway.2005; 15(1):11-18.[56] Pearson G,Robinson F,Beers GT, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.Endocrine Reviews.2001; 22(2):732-737.[57] Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol. 2012;4(11). pii: a011254.[58] Pitcher LA, van Oers NS. T-cell receptor signal transmission: who gives an ITAM?. Trends Immunol. 2003;24(10):554-560.[59] Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature.2004;428(6984):758-763.[60] Mócsai A, Humphrey MB, Van Ziffle JA, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004;101(16):6158-6163.[61] Faccio R, Cremasco V.PLCγ2: where bone and immune cells find their common ground. Ann N Y Acad Sci. 2010;1192: 124-130.[62] Kertész Z, Gy?ri D, Körmendi S, et al. Phospholipase Cγ2 is required for basal but not oestrogen deficiency–induced bone resorption. Eur J Clin Invest. 2012;42(1):49-60.[63] Patterson RL, van Rossum DB, Nikolaidis N, et al. Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci. 2005;30(12):688-697.[64] Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature.2004;428(6984):758-763.[65] Patterson RL, van Rossum DB, Nikolaidis N, et al. Phospholipase C: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci. 2005 Dec;30(12):688-697.[66] Walsh M C, Kim N, Kadono Y, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol.2006;24: 33-63.[67] Kim K, Kim J H, Lee J, et al. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 2005; 280(42):35209-35216.[68] Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol. 2007;143(1):31-48. [69] Matsuo K, Galson D L, Zhao C, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004;279(25): 26475-26480.[70] Asagiri M,Takayanagi H.The molecular understanding of osteoclast differentiation. Bone.2007; 40(40):251-64.[71] Yarilina A, Xu K, Chen J, et al. TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc Natl Acad Sci U S A. 2011; 108(4):1573-1578.[72] Li X,He L,Hu Y,et al.Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways.Plos One.2013;8(9):e74274. |